Advertisement

Durability of Collagenase Treatment for Dupuytren Disease of the Thumb and First Web After at Least 2 Years’ Follow-Up

Published:November 09, 2018DOI:https://doi.org/10.1016/j.jhsa.2018.10.002

      Purpose

      The aim of this study was to analyze the durability of the treatment results of the thumb and first web contractures in Dupuytren disease with collagenase Clostridium histolyticum.

      Methods

      Twelve patients (14 hands) were followed for an average of 35 months (range, 24–42 months). Two patients (3 hands) were excluded, yielding 11 hands available for assessment. Nondurability was defined as a worsening of at least 20° of passive extension deficit at a treated joint or any decrease greater than 5 mm in intermetacarpal head distance, both relative to 30 days after injection or as intervention to correct new/worsening contracture. Durability was compared with that of a historic cohort of treated finger contractures.

      Results

      Five out of 11 patients with a metacarpophalangeal or interphalangeal joint contracture or first web contracture had a nondurable result at an average of 35 months. Results obtained at metacarpophalangeal joints of thumbs were more durable than those of interphalangeal joints. Most of the recurrences occurred in interphalangeal joints.

      Conclusions

      Treatment of thumb and first web contractures was not durable in nearly half of the cases at an average follow-up of 35 months, and durability was clearly less than that of treated finger contractures.

      Type of study/level of evidence

      Therapeutic IV.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hand Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Figus A.
        • Britto J.A.
        • Ragoowansi R.H.
        • Elliot D.
        A clinical analysis of Dupuytren’s disease of the thumb.
        J Hand Surg Eur Vol. 2008; 33: 272-279
        • Milner R.H.
        Dupuytren's disease affecting the thumb and first web of the hand.
        J Hand Surg Br. 2003; 28: 33-36
        • Tubiana R.
        Dupuytren's disease of the radial side of the hand.
        Hand Clin. 1999; 15: 149-159
        • Hueston J.T.
        Dermofasciectomy for Dupuytren's disease.
        Bull Hosp Jt Dis Orthop Inst. 1984; 44: 224-232
        • Badalamente M.A.
        • Hurst L.C.
        Enzyme injection as nonsurgical treatment of Dupuytren's disease.
        J Hand Surg Am. 2000; 25: 629-636
        • Badalamente M.A.
        • Hurst L.C.
        • Hentz V.R.
        Collagen as a clinical target: nonoperative treatment of Dupuytren's disease.
        J Hand Surg Am. 2002; 27: 788-798
        • Badalamente M.A.
        • Hurst L.C.
        Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contracture.
        J Hand Surg Am. 2007; 32: 767-774
        • Hurst L.C.
        • Badalamente M.A.
        • Hentz V.R.
        • et al.
        Injectable collagenase Clostridium histolyticum for Dupuytren's contracture.
        N Engl J Med. 2009; 361: 968-979
        • McFarlane R.M.
        On the origin and spread of Dupuytren's disease.
        J Hand Surg Am. 2002; 27: 385-390
        • Zhao J.Z.
        • Hadley S.
        • Floyd E.
        • Earp B.E.
        • Blazar P.E.
        The impact of collagenase Clostridium histolyticum introduction on Dupuytren treatment patterns in the United States.
        J Hand Surg Am. 2016; 41: 963-968
        • Chen N.C.
        Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture.
        J Hand Surg Am. 2011; 36: 1826-1834
        • Skov S.T.
        Injectable collagenase versus percutaneous needle fasciotomy for Dupuytren contracture in proximal interphalangeal joints: a randomized controlled trial.
        J Hand Surg Am. 2017; 42: 321-328
        • Dreise M.M.
        • Stenekes M.W.
        • Werker P.M.N.
        Collagenase treatment for Dupuytren disease of the thumb and first web.
        J Hand Surg Am. 2016; 41: 348-353.e1
        • Buck-Gramcko D.
        Evaluation criteria in follow-up studies of flexor tendon therapy [in German].
        Handchirurgie. 1976; 8: 65-69
        • Broekstra D.C.
        Intra- and inter-observer agreement on diagnosis of Dupuytren disease, measurements of severity of contracture, and disease extent.
        Man Ther. 2015; 20: 580-586
        • Felici N.
        Dupuytren contracture recurrence project: reaching consensus on a definition of recurrence.
        Handchir Mikrochir Plast Chir. 2014; 46: 350-354
        • Dias J.J.
        • Braybrooke J.
        Dupuytren's contracture: an audit of the outcomes of surgery.
        J Hand Surg Br. 2006; 31: 514-521
        • McMillan C.
        • Binhammer P.
        Steroid injection and needle aponeurotomy for Dupuytren contracture: a randomized, controlled study.
        J Hand Surg Am. 2012; 37: 1307-1312
        • Dias J.J.
        • Singh H.P.
        • Ullah A.
        • Bhowal B.
        • Thompson J.R.
        Patterns of recontracture after surgical correction of Dupuytren disease.
        J Hand Surg Am. 2013; 38: 1987-1993
        • Peimer C.A.
        • Blazar P.
        • Coleman S.
        • et al.
        Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS study): 3-year data.
        J Hand Surg Am. 2013; 38: 12-22
        • Peimer C.A.
        • Blazar P.
        • Coleman S.
        • Kaplan F.T.D.
        • Smith T.
        • Lindau T.
        Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data.
        J Hand Surg Am. 2015; 40: 1597-1605
        • Abe Y.
        • Rokkaku T.
        • Ofuchi S.
        • Tokunaga S.
        • Takahashi K.
        • Moriya H.
        An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease.
        J Hand Surg Br. 2004; 29: 427-430
        • Abe Y.
        Dupuytren's disease on the radial aspect of the hand: report on 135 hands in Japanese patients.
        J Hand Surg Br. 2004; 29: 359-362
        • Tubiana R.
        Location of Dupuytren's disease on the radial aspect of the hand.
        Clin Orthop Relat Res. 1982; 168: 222-229
        • Werker P.M.
        • Pess G.M.
        • van Rijssen Al
        • Denkler K.
        Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions.
        J Hand Surg A. 2012; 37: 2095-2105
        • Leclercq C.
        Results of surgical treatment.
        in: Tubiana R. Leclercq C. Hurst L.C. Badalamente M.A. Mackin E.J. Dupuytren's Disease. Martin Dunitz, London2000: 239-249